Generic Relenza is used to treat flu symptoms caused by influenza virus in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms. More info »
I have received all of my order plus the bonus pills. You not only met my
expectations but greatly exceeded them!
You properly set my expectations by providing me all the information that I would
need during the ordering process and then followed up regularly to insure that all
was occurring as it should.
Your focus on customer service is outstanding and has won me over as a long time
customer. I have already recommended you to two of my friends and will continue to
do so in the future. I am also very pleased with the quality of your product and
accompanying reference materials that I received with my order.
I will do all of my medical business through your firm from this point forward.
Thank you for your proactive efforts and strong customer focused business
practices. I can honestly say my purchase experience has been outstanding!
- Sincerely, Lloyd
Experts Offer Guidance on Use of DAAs for Difficult-To-Treat Hep C Patients - Gastroenterology & Endoscopy News
Gastroenterology & Endoscopy NewsExperts Offer Guidance on Use of DAAs for Difficult-To-Treat Hep C PatientsGastroenterology & Endoscopy Newsby Christina Frangou San Francisco—For several months, it has been one of the most pressing questions among clinicians who treat patients with hepatitis C: How well do the two FDA-approved direct-acting antivirals (DAAs) perform in the patients who .
New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation.
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs .
AIDS Fight Enters New Phase with Prevention Pill - Pharmaceutical Processing
Boston.
FDA advisory panel endorses HIV pill for healthy people - The Seattle Times